Emicizumab is used in the treatment of hemophilia A.
How Emicizumab works In individuals with hemophilia A who have low or absent factor VIII, the blood coagulation process cannot proceed normally. Emicizumab functions as a bridge, connecting factor IXa and factor X to enable the blood coagulation process to continue without the need to replace factor VIII.
Common side effects of Emicizumab include injection site reactions (pain, swelling, redness), joint pain, and headache.
MRP ₹55,218.8
MRP ₹110,340
₹294,392

₹206,044

Flat ₹100 off on first app order | Use Code: APP100 |
Flat ₹100 off on first app order
USE CODE: APP100

Download Now